Gilead Sciences Inc. is in the market to sell $1 billion of senior unsecured bonds Wednesday.

Bank of America Merrill Lynch, J.P. Morgan Chase & Co. and Morgan Stanley are leading the sale.

Proceeds will be used for general corporate purposes such as paying down existing debt and buying back stock, the company said in a regulatory filing.

The notes mature in 10 years and are expected to be rated Baa1 by Moody's Investors Service and A- by Standard & Poor's.

The offering features a change of control put option allowing noteholders to sell their securities back to the issuer at 101% of face value in the event of a merger.

-By Katy Burne, Dow Jones Newswires; 212-416-3084; katy.burne@dowjones.com

 
 
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Gilead Sciences Charts.